| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 123, 203-210, Copyright © 1988 by Endocrine Society
ARTICLES |
I Klein
Department of Medicine, North Shore University Hospital, Manhasset, New York 11030.
To investigate the mechanism of thyroid hormone-induced cardiac hypertrophy, we have studied the in vivo changes in cardiac size and total myocardial content of both membrane and cytoskeletal enzymes in the rat after the administration of excess thyroid hormone. In response to 50 micrograms T4/day, there is a significant increase in heart rate and heart work associated with an increase in total heart size and protein content. Measurements of the specific activity of Na,K-ATPase and p-nitrophenol phosphatase demonstrate a small but significant increase in specific activity, while the specific activity of myosin ATPase is unchanged. To further probe the mechanism for T4-mediated hypertrophy we studied the in vivo effects of beta-adrenergic blockade on rat heart size. When animals were treated with both T4 and propranolol (10 mg/animal.day) cardiac hypertrophy was prevented. Propranolol alone at this dose did not affect heart rate, heart weight, or serum levels of T4 and T3. The present data suggest that 1) the hypertrophic response of the myocardium to excess thyroid hormone involves cytoplasmic as well as membrane proteins, 2) the increase in total myocardial protein, which can be blocked by propranolol, is indirectly mediated by increases in cardiac work rather than a direct effect of thyroid hormone.
This article has been cited by other articles:
![]() |
B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Carneiro-Ramos, G. P. Diniz, J. Almeida, R. L. P. Vieira, S. V. B. Pinheiro, R. A. Santos, and M. L. M. Barreto-Chaves Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism J. Physiol., August 15, 2007; 583(1): 213 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Trivieri, G. Y. Oudit, R. Sah, B.-G. Kerfant, H. Sun, A. O. Gramolini, Y. Pan, A. D. Wickenden, W. Croteau, G. Morreale de Escobar, et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction PNAS, April 11, 2006; 103(15): 6043 - 6048. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vargas, J. M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, and J. Garcia-Estan Vascular and renal function in experimental thyroid disorders Eur. J. Endocrinol., February 1, 2006; 154(2): 197 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Ledda-Columbano, F. Molotzu, M. Pibiri, C. Cossu, A. Perra, and A. Columbano Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes FASEB J, January 1, 2006; 20(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Ralphe, K. Bedell, J. L. Segar, and T. D. Scholz Correlation between myocardial malate/aspartate shuttle activity and EAAT1 protein expression in hyper- and hypothyroidism Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2521 - H2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biondi, E. A. Palmieri, M. Klain, M. Schlumberger, S. Filetti, and G. Lombardi Subclinical hyperthyroidism: clinical features and treatment options Eur. J. Endocrinol., January 1, 2005; 152(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Bachman, T. G. Hampton, H. Dhillon, I. Amende, J. Wang, J. P. Morgan, and A. N. Hollenberg The Metabolic and Cardiovascular Effects of Hyperthyroidism Are Largely Independent of {beta}-Adrenergic Stimulation Endocrinology, June 1, 2004; 145(6): 2767 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fazio, E. A. Palmieri, G. Lombardi, and B. Biondi Effects of Thyroid Hormone on the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 31 - 50. [Abstract] [Full Text] |
||||
![]() |
L. W. Hu, L. A. Benvenuti, E. A. Liberti, M. S. Carneiro-Ramos, and M. L. M. Barreto-Chaves Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1473 - R1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Zhao, T. D. Gallardo, L. Lin, J. J. Schageman, and R. V. Shohet Transcriptional mapping and genomic analysis of the cardiac atria and ventricles Physiol Genomics, December 26, 2002; 12(1): 53 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Weiss, C. Korcarz, O. Chassande, K. Cua, P. M. Sadow, E. Koo, J. Samarut, and R. Lang Thyroid hormone and cardiac function in mice deficient in thyroid hormone receptor-alpha or -beta : an echocardiograph study Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E428 - E435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pachucki, J. Hopkins, R. Peeters, H. Tu, S. D. Carvalho, H. Kaulbach, E. D. Abel, F. E. Wondisford, J. S. Ingwall, and P. R. Larsen Type 2 Iodothyronine Deiodinase Transgene Expression in the Mouse Heart Causes Cardiac-Specific Thyrotoxicosis Endocrinology, January 1, 2001; 142(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ojamaa, A. Kenessey, R. Shenoy, and I. Klein Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1319 - E1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. di Maso, F. Haddad, M. Zeng, S. A. McCue, and K. M. Baldwin Role of denervation in modulating IIb MHC gene expression in response to T3 plus unloading state J Appl Physiol, February 1, 2000; 88(2): 682 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kahaly, S. Wagner, J. Nieswandt, S. Mohr-Kahaly, and T. J. Ryan Stress Echocardiography in Hyperthyroidism J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2308 - 2313. [Abstract] [Full Text] |
||||
![]() |
F. Haddad, A. X. Qin, M. Zeng, S. A. McCue, and K. M. Baldwin Interaction of hyperthyroidism and hindlimb suspension on skeletal myosin heavy chain expression J Appl Physiol, December 1, 1998; 85(6): 2227 - 2236. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kahaly, J. Nieswandt, S. Wagner, J. Schlegel, S. Mohr-Kahaly, and G. Hommel Ineffective Cardiorespiratory Function in Hyperthyroidism J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4075 - 4078. [Abstract] [Full Text] |
||||
![]() |
A. Nishiyama, F. Kambe, K. Kamiya, H. Seo, and J. Toyama Effects of thyroid status on expression of voltage-gated potassium channels in rat left ventricle Cardiovasc Res, November 1, 1998; 40(2): 343 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haddad, A. X. Qin, S. A. McCue, and K. M. Baldwin Thyroid receptor plasticity in striated muscle types: effects of altered thyroid state Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1018 - E1026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |